Medindia

X

Merck’s Experimental Drug Reduces Allergic Reaction to Ragweed

by Kathy Jones on  March 6, 2012 at 9:33 PM Drug News   - G J E 4
Pharmaceutical giant Merck has announced that it will be filing a marketing approval with the US Food and Drug Administration next year for its experimental drug that reduces the allergic reactions to ragweed and grass.
 Merck’s Experimental Drug Reduces Allergic Reaction to Ragweed
Merck’s Experimental Drug Reduces Allergic Reaction to Ragweed
Advertisement

Merck said that the results of its clinical trials revealed that those who took the drugs showed up to 27 percent reduction in the allergy symptoms. More than 560 adults between 18 and 50 years of age took part in the study with the participants given either two different doses of the drug or a placebo.

Advertisement
According to Merck, those who took a lower dose of the drug had 21 percent reduction in symptoms and 34 percent reduction in taking medication compared to the placebo group while those who took the higher dose had 27 percent reduction in symptoms and 45 percent reduction in medication.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All